Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL4000027 | 0.80 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrabuthylammonium SCHEMBL20485063 | 0.77 | SLC22A1 (0.52) | TSHR | |
| Tetrylammonium SCHEMBL1500446 | 0.75 | KDM4E (0.56) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL1006716 | 0.74 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Potassium Ion SCHEMBL6860537 | 0.73 | — | — | |
| SCHEMBL20595137 | 0.73 | — | — | |
| SCHEMBL15917159 | 0.73 | — | — | |
| SCHEMBL15918068 | 0.73 | — | — | |
| SCHEMBL29055217 | 0.73 | CA1 (0.36) | — | |
| Zinc Ion SCHEMBL15917301 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10840504-B2 | High performance inorganic complexes for next-generation redox flow batteries | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2020-11-17 | — | — | US | disclosed |
| US-20180254478-A1 | HIGH PERFORMANCE INORGANIC COMPLEXES FOR NEXT-GENERATION REDOX FLOW BATTERIES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2018-09-06 | — | — | US | disclosed |
| US-20140211370-A1 | Electrochemical Cell, Related Material, Process for Production, and Use Thereof | IONOVA TECHNOLOGIES, INC. (US) | 2014-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10840504-B2 | High performance inorganic complexes for next-generation redox flow batteries | ACAD9, LETM1, NOX4 | TSHR 4537/4885NFKB1 1658/4885KCNA1 1365/4885 |
| US-20180254478-A1 | HIGH PERFORMANCE INORGANIC COMPLEXES FOR NEXT-GENERATION REDOX FLOW BATTERIES | ACAD9, LETM1, NOX4 | TSHR 4537/4885NFKB1 1658/4885KCNA1 1365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.